Eli Lilly's new program aims to boost employer coverage of GLP-1s / Endpoints
Shelby Livingston / endpoints - With insurance coverage of weight loss medications stalled, Eli Lilly has developed a program to give employers another way to pay for their workers' GLP-1 treatments. The pharma giant on Thursday announced the launch of ...
#obesity #healthcare #pharmaceuticals #drugpricing #elililly #weightloss #healthcarefinance
Saturday, March 7, 2026, 10:21 pm / permalink 20341 / 16 stories in 3 days
Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC / Healthcare Dive
Rebecca Pifer Parduhn / healthcaredive - It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last month.
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #healthcarefinance
Saturday, March 7, 2026, 12:23 am / permalink 20308 / 3 stories in 4 days
Hospitals urge regulators to halt drugmakers’ expanded 340B data policies / Healthcare Dive
Emily Olsen / healthcaredive - The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #hospitaloperations #healthcarefinance
Friday, March 6, 2026, 12:23 pm / permalink 20277 / 4 stories in 4 days
AbbVie sues over selection of Botox for IRA negotiations / Endpoints
Nicole DeFeudis / endpoints - AbbVie is suing CMS for picking Botox for the third round of Medicare negotiations, making it the first drugmaker to challenge the upcoming cycle in court. In a lawsuit filed Wednesday in Washington, DC, AbbVie ...
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy
Saturday, February 14, 2026, 12:22 am / permalink 19169 / 2 stories in 25 days
HHS to drop 340B rebate pilot after court rulings / Beckers
Ella Jeffries / beckershospitalreview - HHS will drop its 340B rebate model pilot program following two federal court rulings that blocked its implementation. The program, announced in August 2025, was challenged by the American Hospital Association, the Maine Hospital Association and four safe…
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy
Saturday, February 7, 2026, 6:21 am / permalink 18879 / 3 stories in 4 wks
HHS scraps 340B rebate pilot in win for hospitals / Healthcare Dive
Emily Olsen / healthcaredive - The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates on some drugs instead of upfront discounts.
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy
Saturday, February 7, 2026, 12:23 am / permalink 18867 / 5 stories in 4 wks
Novo Nordisk vows legal action to protect Wegovy pill / Medical Express
medicalxpress - Novo Nordisk said Thursday it would take legal action against a US chain offering a copycat of the new pill version of its Wegovy weight-loss drug.
#obesity #healthcare #pharmaceuticals #drugpricing #novonordisk #weightloss #drugdevelopment #digitalhealth
Thursday, February 5, 2026, 3:23 pm / permalink 18807 / 22 stories in 4 wks
FTC deal over insulin prices forces Express Scripts to overhaul policies / Beckers
Elizabeth Casolo / beckershospitalreview - The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. Under the settlement, Express Scripts must keep drug manufacturer compensation de…
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy
Wednesday, February 4, 2026, 3:25 pm / permalink 18768 / 6 stories in 4 wks
‘Vertical integration is destroying people’s ability to access care’: Payer CEOs face bipartisan congressional grilling / Beckers
Jakob Emerson / beckershospitalreview - The CEOs of the nation’s largest health insurers drew the ire of lawmakers on both sides of the aisle during congressional hearings Jan. 22 over industry consolidation, prior authorization practices and executive pay, with members pressing executives to e…
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #mergersandacquisitions #corporatetakeover
Thursday, January 22, 2026, 9:22 pm / permalink 18314 / 27 stories in 6 wks
Compounding pharmacy sues Eli Lilly, Novo Nordisk over GLP-1 access / Beckers
Ella Jeffries / beckershospitalreview - Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 medications and suppress competition. The lawsuit, filed i…
#obesity #healthcare #pharmaceuticals #drugpricing #elililly #novonordisk #weightloss #publichealth #biotech
Thursday, January 15, 2026, 1:23 pm / permalink 17926 / 4 stories in 7 wks
Judge blocks 340B rebate pilot program / Beckers
Ella Jeffries / beckershospitalreview - A federal judge granted a temporary restraining order blocking the Department of Health and Human Services from launching its 340B Rebate Model Pilot Program, which was scheduled to begin Jan. 1, 2026. U.S. District Judge Lance Walker of the District of M…
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy
Saturday, January 3, 2026, 7:22 am / permalink 17451 / 5 stories in 2 months
House floats new healthcare bill after Senate proposals fail / Beckers
Andrew Cass / beckershospitalreview - House Republicans have unveiled new healthcare legislation in the wake of votes in the Senate that failed to pass bills addressing expiring ACA enhanced subsidies. Seven things to know: 1. The House Republicans’ proposal does not extend the subsidies that…
#healthcare #drugpricing #publichealth #governmentpolicy
Saturday, December 20, 2025, 12:21 pm / permalink 17171 / 10 stories in 2 months
Optum Rx: 100% of network community pharmacies shift to cost-based model / Fierce
fiercehealthcare - Earlier this year, Optum Rx announced that it would shift to a cost-based model, which would boost reimbursements for brand-name drugs at community pharmacies.
#healthcare #pharmaceuticals #drugpricing #corporatetakeover
Friday, December 19, 2025, 5:22 am / permalink 17127 / 4 stories in 2 months
ACA approval hits new high as subsidies set to expire: 7 things to know / Beckers
Alan Condon / beckershospitalreview - Approval of the ACA recently climbed to a new high of 57% — driven largely by a surge in support among independents — even as pandemic‑era enhanced subsidies are set to expire Dec. 31 unless Congress acts, according to a survey published Dec. 8 by the Wes…
#healthcare #drugpricing #publichealth #governmentpolicy
Monday, December 8, 2025, 12:22 pm / permalink 16702 / 21 stories in 3 months
CVS Health agrees to pay $37.8M to settle fraud allegations over insulin pens / Fierce
fiercehealthcare - CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and improperly billed federal healthcare programs for those prescriptions.
#healthcare #pharmaceuticals #drugpricing #publichealth #corporatetakeover
Monday, December 8, 2025, 12:21 am / permalink 16679 / 2 stories in 3 months
UK and US agree zero-tariff deal on pharmaceuticals / ABC News
go - Officials say the U.K. has sealed a deal securing a 0% tariff rate for all U.K. medicines exported to the U.S. for at least 3 years, in return for the U.K. spending more on new medicines
#healthcare #pharmaceuticals #drugpricing #governmentpolicy
Monday, December 1, 2025, 1:23 pm / permalink 16444 / 6 stories in 3 months
Novo Nordisk rolls out lower prices for Ozempic and Wegovy / Medical Express
medicalxpress - People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.
#obesity #healthcare #pharmaceuticals #drugpricing #novonordisk #weightloss #publichealth #biotech
Thursday, November 20, 2025, 1:22 am / permalink 16131 / 6 stories in 3 months
CMS unveils new Medicaid drug payment model / Endpoints
Max Bayer / endpoints - CMS plans to launch a new drug payment model for state Medicaid programs, the first of potentially multiple pricing models under President Donald Trump's "most favored nation" push that the pharma industry has been closely ...
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy
Saturday, November 8, 2025, 12:21 am / permalink 15785 / 3 stories in 4 months
What Trump’s New Drug Pricing Deal Means for People With Obesity / NYT
Rebecca Robbins, Dani Blum and Margot Sanger-Katz / nytimes - The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.
#trumpadministration #obesity #healthcare #pharmaceuticals #drugpricing #elililly #novonordisk #weightloss #publichealth #governmentpolicy
Friday, November 7, 2025, 11:57 pm / permalink 15780 / 6 stories in 4 months